OpenCharities

Alk+ International

Country
England & Wales
Charity number
1199634
Status
Registered
Registered
July 12, 2022
Legal form
Trust

Address

Address
21 Northfield
Hartley
LONGFIELD
Kent
DA3 7EW

Activities

ALK International is patient and family-led, created with a single mission:To improve the life expectancy for ALK positive cancer patients.We do this by:Fundraising;drive the most vital research for ALK by providing grants for projects/clinical trials.Advocating;improvements to treatment/clinical trial availablity for patients and help accelerate lifesaving ALK advances.

Objects: To Relieve The Sickness And To Preserve And Protect The Good Health Of Patients With Anaplastic Lymphoma Kinase Positive (Alk+) Cancer In Particular, But Not Exclusively, By: A. Awarding Grants For Research Into The Nature, Diagnosis, Prevention And Cure For Alk Cancer, The Useful Results Of Which Will Be Published.b. Working With Other Charities And Organisations To Create Campaigns That Will Raise Public Awareness Of Alk Cancer;c. Advocating For Improvements To Treatment And Clinical Trial Availability, By Liaising With Government, Pharmaceutical Companies, Regulatory Bodies And Other Organisations;d. Identifying And Locating Alk Patients And Offering Them Information And Support;e. The Provision Of Resources Such As A Website And Social Media Support Groups That Will Connect Patients And Educate The General Public And Keep Them Informed Of The Most Up-To-Date Developments On The Advancement Of Treatments And Research, And;f. Raising Funds For The Above Purposes.

Classification

How
Makes Grants To Organisations, Sponsors Or Undertakes Research, Other Charitable Activities
What
The Advancement Of Health Or Saving Of Lives
Who
Other Defined Groups, The General Public/mankind

Areas of operation

Region
Throughout England And Wales

Finances

Period end Income Expenditure
March 31, 2025 £19,400 —
March 31, 2024 £55,870 £48,746
March 31, 2023 £59,202 —

Trustees

Name Appointed
James Gibbard (Chair) Feb. 4, 2022
Caroline Goddard Oct. 9, 2024
Catherine Gibbard Feb. 4, 2022
Joanna Jonathan Feb. 4, 2022